ReviewNature reviews. Nephrology2026
The endothelium response to kidney injury.
Review in Nature reviews. Nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Insights from integrative spatial transcriptomics in sepsis-associated acute kidney injury.Nature reviews. Nephrology · 2026Review
- Renal Tubular Epithelial Cells as Central Hubs of Kidney Disease.Diagnostics (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The kidney contains a heterogeneous endothelial cell population, with each subset serving distinct roles in the maintenance of tissue homeostasis and support of kidney function. This diverse cellular population comprises three broad subsets: vascular, glomerular and lymphatic endothelia. The vascular endothelium, which in this context refers to all vascular endothelial cells apart from those in the glomeruli and lymph vessels, supports parenchymal cells by delivering oxygen and nutrients, removing metabolic waste and facilitating tubular secretion and reabsorption processes. Although similar, the glomerular endothelium is a highly specialized capillary system designed to maintain the glomerular filtration barrier by selectively permitting the passage of water and electrolytes into the tubular filtrate while preventing the passage of cells and large solutes. The lymphatic endothelium aids the reabsorption of extracellular fluid and trafficking of immune cells out of the kidney to draining lymph nodes. These kidney endothelial populations undergo marked changes following kidney injury, involving the increased production of inflammatory cytokines, reduced expression of angiogenic and vasodilatory molecules and loss of the glycocalyx, which can result in endothelial dysfunction, capillary rarefaction and impaired barrier function, and can influence outcomes towards recovery or progressive damage. Improved understanding and an ability to therapeutically target the kidney endothelium after injury may lead to improved care and outcomes in kidney disease.
Indexed as
Identifiers
41872605What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.